NCT01585623 2025-03-05
Drug Interaction Study of SAR302503 in Patients With Solid Tumor
Bristol-Myers Squibb
Phase 1 Completed
Bristol-Myers Squibb
Chinese PLA General Hospital
Kuopio University Hospital
University Hospital, Akershus
European Institute of Oncology